Sanket Shah, MBBS, PhD
Director, Global Value & HEOR
Gaithersburg, Maryland, United States · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
I'm a physician who decided the most leverage I could apply to patient outcomes wasn't at the bedside — it was upstream, at the intersection of clinical evidence and commercial strategy. That conviction has shaped a career spanning emergency medicine, global biopharma, and early-stage healthtech investing. Today I lead Global Value and HEOR at Jazz Pharmaceuticals, where I optimize reimbursement focused trial design for pipeline assets and lead HEOR for inline. I also sit on the buy-side BD&L team — evaluating pipeline assets, structuring in-licensing strategy, and building the payer value frameworks that determine whether a medicine actually reaches patients at scale. Before Jazz, I supported the commercial foundation for Trikafta's European launch at Vertex Pharmaceuticals — one of the most consequential rare disease access stories of the last decade. That experience crystallized something: payer strategy isn't a late-stage activity. It has to be embedded in trial design, endpoint selection, and evidence generation from day one. That upstream philosophy is the throughline of everything I do. At Jazz, it means shaping the value narrative for rare pediatric oncology assets long bef
Experience
Jul 2021
Mar 2016
Aug 2020 to Sep 2021
Jan 2019 to Jun 2023
Aug 2017 to Aug 2018
Aug 2016 to Dec 2016
Jun 2016 to Aug 2016
Feb 2012 to May 2013
Jan 2013 to Feb 2013
Education
Ph.D. Health Outcomes and Pharmacy Practice | Minor: Business
2013 to 2018
Ph.D. Health Outcomes and Pharmacy Practice | Minor: Business
2013 to 2018
Bachelor of Medicine Bachelor of Surgery (M.B.B.S.) (US equivalent of MD), Medicine
2007 to 2013